For research use only. Not for therapeutic Use.
Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitor[1].
| Catalog Number | I043534 |
| CAS Number | 1978336-95-6 |
| Synonyms | (2R,3R,4S,5R,6R)-2-(5-bromopyridin-3-yl)sulfanyl-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)triazol-1-yl]oxane-3,5-diol |
| Molecular Formula | C19H16BrF3N4O4S |
| Purity | ≥95% |
| InChI | InChI=1S/C19H16BrF3N4O4S/c20-9-3-10(5-24-4-9)32-19-18(30)16(17(29)14(7-28)31-19)27-6-13(25-26-27)8-1-11(21)15(23)12(22)2-8/h1-6,14,16-19,28-30H,7H2/t14-,16+,17+,18-,19-/m1/s1 |
| InChIKey | FNCLKJPMEFPXOR-QFACEVIFSA-N |
| SMILES | C1=C(C=C(C(=C1F)F)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4=CC(=CN=C4)Br)CO)O |
| Reference | [1]. Slack RJ, et al. The therapeutic potential of galectin-3 inhibition in fibrotic disease. Int J Biochem Cell Biol. 2021 Jan;130:105881. |
